The uptake of a fluorescently labelled antisense oligonucleotide in vitro and in vivo

Journal of Neuroscience Methods

Volumn 147, Issue 1, 2005, Pages 48-54

  Robinson, Emma S J ^a   Nutt, David J ^b   Jackson, Helen C ^c,d   Hudson, Alan L ^b  

^a SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ABBOTT LABORATORIES   (United States)

^d RenaSci Ltd   (United Kingdom)

Author keywords

Antisense; Fluorescence microscopy; In vivo; Primary cortical neurones; Rat; Uptake

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; FLUORESCENT DYE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CELL; CELL POPULATION; CEREBROSPINAL FLUID; FEMALE; FLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCEPHALON; NEWBORN; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; RAT; RHOMBENCEPHALON; TISSUE DISTRIBUTION; TRANSPORT KINETICS;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CEREBRAL CORTEX; DRUG ADMINISTRATION ROUTES; FLUORESCEIN; MALE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS; RATS, WISTAR;

EID: 23044442682     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2005.03.003     Document Type: Article

References (27)

1. S. Agrawal, J. Temsamani, and Y.T. Jin Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice Proc Natl Acad Sci USA 88 1991 7595 7599
2. S. Akhtar, and R.L. Juliano Cellular uptake and intracellular fate of antisense oligonucleotides Trends Cell Biol 2 1992 139 144
3. 2-adrenoceptors in the rat brain Mol Neuropharmacol 1 1992 219 229
4. H. Manev, S. Caredda, and D.R. Grayson Nonselective inhibition by antisense oligonucleotides of cytosine arabinoside action Neuroreport 2 1991 589 592
5. A.P. Nicholas, T. Hokfelt, and V.A. Pieribone The distribution and significance of CNS adrenoceptors examined with in situ hybridization Trends Pharmacol Sci 17 1996 245 255
6. 2-adrenoceptors and blood pressure regulation in the rat Eur J Pharmacol 278 1995 183 185
7. G. Paxinos, and C. Watson The rat brain stereotaxic coordinates 1983 Academic Press New York
8. 2 dopamine receptors Mol Pharmacol 48 1995 730 737
9. 2-adrenoceptor expression M.I. Phillips Methods in enzymology: antisense technology, Part B, applications vol. 314 1999 Academic Press San Diego 61 76
10. 2D-adrenoceptor in the rat Br J Pharmacol 128 1999 515 522
11. 2D subtype J Psychopharmacol 10 Suppl. 1996 A16
12. E.S.J. Robinson, D.J. Nutt, H.C. Jackson, and A.L. Hudson Antisense oligonucleotides in psychopharmacology and behaviour: promises and pitfalls J Psychopharmacol 11 1997 259 269
13. 2D-adrenoceptors in the rat Br J Pharmacol 130 2000 153 159
14. R. Schlingensiepen, and I. Klinger Cell culture protocols R. Schlingensiepen W. Brysch K.-H. Schlingensiepen Antisense - from technology to therapy. Lab manual and textbook 1997 Blackwell Science Berlin 127
15. W. Sommer, B. Bjelke, D. Ganten, and K. Fuxe Antisense oligonucleotide to c-fos induces ipsilateral rotational behaviour to d-amphetamine Neuroreport 5 1993 277 280
16. C.A. Stein, K. Mori, S.L. Loke, C. Subasinghe, K. Shinozuka, and J.S. Cohen Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: characterization and preliminary kinetics of cellular uptake Gene 72 1988 333 341
17. C. Sumners, W. Tang, B. Zelezna, and M.K. Raizada Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurones and astrocytes from rats brain Proc Natl Acad Sci USA 88 1991 7567 7571
18. A. Szklarczyk, and L. Kaczmarek Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain J Neurosci Meth 60 1995 181 187
19. W. Tischmeyer, R. Grimm, H. Schichnick, W. Brysch, and K.-H. Schlingensiepen Sequence-specific impairment of learning by c-jun antisense oligonucleotides Neuroreport 5 1994 1501 1504
20. C. Wahlestedt, E. Golanov, S. Yamamoto, F. Yee, H. Ericson, and H. Yoo Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurones from excitotoxicity and reduce focal ischaemic infarctions Nature 363 1993 260 263
21. C. Wahlestedt, E. Merlo-Pich, G.F. Koob, F. Yee, and M. Heilig Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides Science 259 1993 528 531
22. B. Weiss, G. Davidkova, and S.-P. Zhang Antisense strategies in neurobiology Neurochem Int 31 1997 321 348
23. L. Whitesell, D. Geselowitz, C. Chavany, B. Fahmy, S. Walbridge, and J.R. Alger Stability, clearance and deposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system Proc Natl Acad Sci USA 90 1993 4665 4669
24. Y. Yaida, and T.S. Nowak Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridisation Regul Pept 59 1995 193 199
25. L.A. Yakubov, E.A. Deeva, V.F. Zarytova, E.M. Ivanova, A.S. Ryte, and L.V. Yurchenko Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 86 1989 6454 6458
26. F. Yee, H. Ericson, D. Reis, and C. Wahlestedt Cellular uptake of intracerebroventricular administered biotin- or digoxigenin-labelled antisense oligodeoxynucleotides in the rat Cell Mol Neurobiol 14 1994 475 485
27. 2 dopamine antisense oligodeoxynucleotide in mouse brain J Mol Neurosci 7 1996 13 28